Microsoft
MSFT
533.52
+4.47
+0.84%
Microsoft
US · MSFT
#5 by market cap
Listed 1986
533.52
+4.47
+0.84%
Live - 5344 symbols - heartbeat 69s ago
· 2026-10-20 06:40
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 9.30, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +17.79% YoY
Margins
- Gross margin
- 67.94%
- Operating margin
- 46.78%
- Net margin
- 40.31%
Key ratios & quality
- Enterprise valuei
- 3.93T
- PEG ratioi
- 1.31
- Altman Z-Scorei
- 9.30
PEG uses trailing P/E against the 3-year net income growth rate (22.72%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 125.84B | 143.02B | 168.09B | 198.27B | 211.92B | 245.12B | 281.72B | 331.84B |
| Gross profit | 82.93B | 96.94B | 115.86B | 135.62B | 146.05B | 171.01B | 193.89B | 225.47B |
| Selling & admin expenses | 23.10B | 24.71B | 25.22B | 27.73B | 30.33B | 32.07B | 32.88B | 34.67B |
| Research & development | 16.88B | 19.27B | 20.72B | 24.51B | 27.20B | 29.51B | 32.49B | 35.56B |
| Operating profit | 42.96B | 52.96B | 69.92B | 83.38B | 88.52B | 109.43B | 128.53B | 155.24B |
| Pretax profit | 43.69B | 53.04B | 71.10B | 83.72B | 89.31B | 107.79B | 123.63B | 165.93B |
| Tax | 4.45B | 8.76B | 9.83B | 10.98B | 16.95B | 19.65B | 21.80B | 32.19B |
| Net profit | 39.24B | 44.28B | 61.27B | 72.74B | 72.36B | 88.14B | 101.83B | 133.75B |
| Basic EPS | 5 | 6 | 8 | 10 | 10 | 12 | 14 | 18 |
| Diluted EPS | 5.06 | 5.76 | 8.05 | 9.65 | 9.68 | 11.80 | 13.64 | 17.95 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 70.07B | 76.44B | 77.67B | 81.27B | 82.89B | 90.01B |
| Gross profit | 48.15B | 52.43B | 53.63B | 55.30B | 56.06B | 60.48B |
| Selling & admin expenses | 7.95B | 9.28B | 7.52B | 8.52B | 8.75B | 9.88B |
| Research & development | 8.20B | 8.83B | 8.15B | 8.50B | 8.92B | 10.00B |
| Operating profit | 32.00B | 34.32B | 37.96B | 38.28B | 38.40B | 40.60B |
| Pretax profit | 31.38B | 32.62B | 34.30B | 48.25B | 39.34B | 44.05B |
| Tax | 5.55B | 5.38B | 6.55B | 9.79B | 7.56B | 8.28B |
| Net profit | 25.82B | 27.23B | 27.75B | 38.46B | 31.78B | 35.77B |
| Basic EPS | 3 | 4 | 4 | 5 | 4 | 5 |
| Diluted EPS | 3.46 | 3.65 | 3.72 | 5.16 | 4.27 | 4.81 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 175.55B | 181.92B | 184.41B | 169.68B | 184.26B | 159.73B | 191.13B | 207.71B |
| Cash & ST investments | 133.83B | 136.49B | 130.26B | 104.75B | 111.26B | 75.53B | 94.56B | 76.65B |
| Inventory | 2.06B | 1.90B | 2.64B | 3.74B | 2.50B | 1.25B | 938.00M | 1.40B |
| Total assets | 286.56B | 301.31B | 333.78B | 364.84B | 411.98B | 512.16B | 619.00B | 758.38B |
| Total current liabilities | 69.42B | 72.31B | 88.66B | 95.08B | 104.15B | 125.29B | 141.22B | 168.83B |
| Short-term debt | 5.52B | 3.75B | 8.07B | 2.75B | 5.25B | 8.94B | 3.00B | 9.23B |
| Long-term debt | 66.66B | 59.58B | 50.07B | 47.03B | 41.99B | 42.69B | 40.15B | 31.07B |
| Total liabilities | 184,226,000,000.00 | 183,007,000,000.00 | 191,791,000,000.00 | 198,298,000,000.00 | 205,753,000,000.00 | 243,686,000,000.00 | 275,524,000,000.00 | 315,989,000,000.00 |
| Total equity | 102.33B | 118.30B | 141.99B | 166.54B | 206.22B | 268.48B | 343.48B | 442.39B |
| Retained earnings | 24.15B | 34.57B | 57.06B | 84.28B | 118.85B | 173.14B | 237.73B | 328.27B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 156.64B | 191.13B | 189.07B | 180.19B | 175.33B | 207.71B |
| Cash & ST investments | 79.61B | 94.56B | 102.01B | 89.46B | 78.23B | 76.65B |
| Inventory | 848.00M | 938.00M | 1.13B | 1.06B | 1.22B | 1.40B |
| Total assets | 562.62B | 619.00B | 636.35B | 665.30B | 694.23B | 758.38B |
| Total current liabilities | 114.21B | 141.22B | 135.00B | 130.01B | 136.66B | 168.83B |
| Short-term debt | 3.00B | 3.00B | 7.83B | 4.84B | 8.84B | 9.23B |
| Long-term debt | 39.88B | 40.15B | 35.38B | 35.43B | 31.42B | 31.07B |
| Total liabilities | 240,733,000,000.00 | 275,524,000,000.00 | 273,275,000,000.00 | 274,427,000,000.00 | 279,861,000,000.00 | 315,989,000,000.00 |
| Total equity | 321.89B | 343.48B | 363.08B | 390.88B | 414.37B | 442.39B |
| Retained earnings | 219.76B | 237.73B | 254.87B | 280.79B | 302.53B | 328.27B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 52.19B | 60.68B | 76.74B | 89.04B | 87.58B | 118.55B | 136.16B | 182.94B |
| Depreciation & amortization | 11.68B | 12.80B | 11.69B | 14.46B | 13.86B | 20.96B | 29.43B | 38.53B |
| Free cash flow | 38.26B | 45.23B | 56.12B | 65.15B | 59.48B | 74.07B | 71.61B | 66.99B |
| Dividends paid | -13.81B | -15.14B | -16.52B | -18.14B | -19.80B | -21.77B | -24.08B | -26.45B |
| Stock buybacks / issuance | -18.40B | -21.63B | -25.69B | -30.86B | -20.38B | -15.25B | -16.36B | -20.26B |
| Ending cash balance | 11.36B | 13.58B | 14.22B | 13.93B | 34.70B | 18.32B | 30.24B | 20.94B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 37.04B | 42.65B | 45.06B | 35.76B | 46.68B | 55.44B |
| Depreciation & amortization | 7.73B | 9.32B | 13.06B | 9.20B | 10.17B | 11.02B |
| Free cash flow | 20.30B | 25.57B | 25.66B | 5.88B | 15.80B | 19.64B |
| Dividends paid | -6.17B | -6.17B | -6.17B | -6.76B | -6.76B | -6.76B |
| Stock buybacks / issuance | -4.24B | -4.00B | -4.96B | -7.16B | -4.09B | -4.06B |
| Ending cash balance | 28.83B | 30.24B | 28.85B | 24.30B | 32.11B | 20.94B |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 42.41 | 40.14 | 47.08 | 47.15 | 38.82 | 37.13 | 33.28 | 34.04 |
| ROA %i | 14.39 | 15.07 | 19.30 | 20.82 | 18.63 | 19.07 | 18.00 | 19.42 |
| ROIC %i | 22.69 | 23.90 | 30.80 | 33.23 | 28.96 | 29.23 | 27.48 | 29.57 |
| 5-year avg ROE %i | 27.03 | 32.19 | 36.20 | 39.25 | 43.12 | 42.07 | 40.69 | 38.09 |
| EBIT margin %i | 36.85 | 38.90 | 43.70 | 43.26 | 43.07 | 45.17 | 44.73 | 50.92 |
| FCF / sales %i | 30.40 | 31.63 | 33.39 | 32.86 | 28.07 | 30.22 | 25.42 | 20.19 |
| Current ratioi | 2.53 | 2.52 | 2.08 | 1.78 | 1.77 | 1.27 | 1.35 | 1.23 |
| Quick ratioi | 2.35 | 2.33 | 1.90 | 1.57 | 1.54 | 1.06 | 1.16 | 0.93 |
| Debt / assetsi | 27.35 | 23.56 | 20.31 | 16.79 | 14.56 | 13.11 | 9.79 | 7.49 |
| LT debt / equityi | 71.19 | 56.84 | 42.05 | 35.14 | 26.53 | 21.67 | 16.77 | 10.76 |
| Interest coveragei | 17.27 | 21.47 | 31.31 | 41.58 | 46.38 | 37.72 | 52.84 | 55.39 |
| Revenue CAGR (3Y) %i | 11.35 | 13.98 | 15.06 | 16.36 | 14.01 | 13.40 | 12.42 | 16.12 |
| Net income CAGR (3Y) %i | 24.08 | 20.21 | 54.63 | 22.84 | 17.79 | 12.88 | 11.87 | 22.72 |
| FCF CAGR (3Y) %i | 15.27 | 12.97 | 20.28 | 19.41 | 9.55 | 9.69 | 3.20 | 4.04 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 33.61 | 33.28 | 32.24 | 34.39 | 34.01 | 34.04 |
| ROA %i | 18.46 | 18.00 | 18.10 | 19.89 | 19.93 | 19.42 |
| ROIC %i | 27.00 | 27.48 | 27.06 | 29.22 | 29.24 | 29.57 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 44.71 | 44.73 | 44.30 | 48.84 | 49.43 | 50.92 |
| FCF / sales %i | 25.69 | 25.42 | 26.55 | 25.34 | 22.91 | 20.19 |
| Current ratioi | 1.37 | 1.35 | 1.40 | 1.39 | 1.28 | 1.23 |
| Quick ratioi | 1.15 | 1.16 | 1.15 | 1.12 | 1.01 | 0.93 |
| Debt / assetsi | 10.77 | 9.79 | 9.52 | 8.66 | 8.21 | 7.49 |
| LT debt / equityi | 17.88 | 16.77 | 14.52 | 13.50 | 11.61 | 10.76 |
| Interest coveragei | 48.86 | 52.84 | 52.04 | 56.44 | 55.65 | 55.39 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- Productivity and Business Processes is the largest reported line at 42.19% of revenue, across 3 reported segments.
- No single line clears half of revenue; Intelligent Cloud is next at 41.52%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
Productivity and Business Processes42.19%
Intelligent Cloud41.52%
More Personal Computing16.29%
Region
United States51.47%
Other countries48.53%
Quote time 2026-10-20 06:40:10 · For reference only, not investment advice and not tailored to your situation.
Azure growth numbers last quarter were solid but the stock barely moved, feels like expectations are just priced for perfection at this market cap.